RNase-L mediates critical cellular functions including antiviral, pro-apoptotic, and tumor suppressive activities; accordingly, its expression must be tightly regulated. Little is known about the control of RNase-L expression; therefore, we examined the potential regulatory role of a conserved 3'-untranslated region (3'UTR) in its mRNA. The 3'UTR mediated a potent decrease in the stability of RNase-L mRNA, and of a chimeric beta-globin-3'UTR reporter mRNA. AU-rich elements (AREs) are cis-acting regulatory regions that modulate mRNA stability. Eight AREs were identified in the RNase-L 3'UTR, and deletion analysis identified positive and negative regulatory regions associated with distinct AREs. In particular, AREs 7 and 8 served a strong positive regulatory function. HuR is an ARE binding protein that stabilizes ARE-containing mRNAs, and a predicted HuR binding site was identified in the region comprising AREs 7 and 8. Co-transfection of HuR and RNase-L enhanced RNase-L expression and mRNA stability in a manner that was dependent on this 3'UTR region. Immunoprecipitation demonstrated that RNase-L mRNA associates with a HuR containing complex in intact cells. Activation of endogenous HuR by cell stress, or during myoblast differentiation, increased RNase-L expression, suggesting that RNase-L mRNA is a physiologic target for HuR. HuR-dependent regulation of RNase-L enhanced its antiviral activity demonstrating the functional significance of this regulation. These findings identify a novel mechanism of RNase-L regulation mediated by its 3'UTR.
The control of mRNA stability is a potent regulatory mechanism, as small changes in mRNA half-life result in dramatic changes in the mRNA available for translation into functional protein.
Such post-transcriptional regulation provides a means to rapidly alter gene expression in response to diverse stimuli, and is frequently observed in genes encoding proteins with essential cellular functions such as proliferation and stress response. One of the most extensively studied RNA decay pathways involves AU-rich elements (AREs 1 ) present in the 3'-untranslated region (3'UTR) of mRNAs (1) . The AUUUA sequence is a loose consensus that is found in many but not all AREs; the absence of a strict sequence motif likely reflects the importance of structural components in ARE function (2) . The influence of AREs on mRNA turnover occurs through an interaction with ARE binding proteins (AREBPs) that can function to destabilize or stabilize target mRNAs by modulating access to the decay machinery. Specifically, AREs modulate deadenylation, and decapping, two critical steps in mRNA decay (3, 4) ; consistent with a link between mRNA stability and translation, some AREBPs function to regulate translation (5, 6) . Several AREBPs have been identified, and genetic manipulation of specific AREBPs in mice, such as HuR and tristetraprolin (TTP), resulted in dramatic and complex phenotypes that are associated with inflammation and stress response (7, 8) . These phenotypes underscore the critical role of AREBPs in gene regulation in physiological and pathophysiological processes. It is estimated that 5-8% of the mRNAs in the human transcriptome contain putative ARE elements (9) . The current challenge lies in determining the specific mRNA targets of AREBPs that are responsible for the 2 phenotypes associated with ARE-mediated regulation.
RNase-L is the terminal component of an RNA decay pathway known as the 2-5A system that derives its name from the 2',5'-linked oligoadenylates (pppA(2'p5'A) n n >2) that are required for its activation (10) . A family of 2',5'-oligoadenylate synthetases (OAS) are activated by double-stranded RNA to polymerize ATP into 2-5A. 2 -5A, in turn, binds t he latent RNase-L resulting in its dimerization and activation. Activated RNase-L cleaves single-stranded viral, ribosomal, and mRNAs with a preference for UU and UA sequences. In addition to its nuclease function, a role for RNase-L in translational regulation was recently reported (11) . RNase-L activity is attenuated by the inactivation of 2-5A by cellular phosphatases and a 2'phosphodiesterase (12) , and by RLI, a protein inhibitor of RNase-L (13). The 2-5A system is an established mediator of interferon (IFN)-induced antiviral activity, and genetic approaches to manipulate RNase-L expression and activity revealed that it exerts potent antiproliferative, proapoptotic, and senescence-inducing activities independent of IFN treatment and virus infection (14) (15) (16) . Consistent with a broader role for RNase-L as a natural constraint on cell proliferation, RNase-L was determined to function as a tumor suppressor by mapping of the hereditary prostate cancer-1 susceptibility allele ( HPC1) to the RNASEL gene locus (17) , and by the association of RNase-L mutations with the disease (18) . Most recently, a novel gamma retrovirus was detected at a high frequency in prostate cancer patients that were homozygous for the Arg->462->Gln RNase-L mutation, suggesting a functional overlap between its antiviral a nd tumor suppressor activities (19) . A few cellular mRNAs that are degraded in an RNase-L-dependent manner have been identified, but a direct substrate relationship with RNase-L, and a role in mediating RNase-L antiproliferative activities, has not been established for any candidate substrate (20) (21) (22) . Microarray analysis of 2 -5A-induced gene expression in prostate cancer cells (23) and human diploid fibroblasts ( JBA, XL and BAH unpublished) identified a finite number of downregulated genes that represent candidate RNase-L substrates, and determined that a significant number of mRNAs were upregulated following RNase-L activation. These findings suggest that the biological activities of RNase-L involve a n extensive reprogramming of one or more gene regulatory networks.
As a mediator of the cellular response to microbial and antiproliferative s tress stimuli, RNase-L must be rapidly activated then efficiently attenuated, to prevent the deleterious effects of its uncontrolled activity in cells. However, apart from activation by 2 -5A, little is known about the regulation of RNase-L activity. OAS transcription is markedly induced by IFN, antiproliferative agents, or cell stress, providing a source of 2-5A in physiological conditions that require RNase-L activity. In contrast, RNase-L mRNA and protein are present at low basal levels in most cell types, and its enzyme activity is not associated with significant changes in RNase-L transcription (24) . These findings suggested that RNase-L expression may be rapidly and transiently regulated by posttranscriptional mechanisms. Specifically, the presence of a conserved, 1.75 kb 3'UTR in the RNase-L transcript, prompted us to examine the role of RNase-L mRNA stability in the regulation of its expression. The RNase-L 3'UTR contained multiple candidate AREs, and sequential deletion of these elements identified positive and negative regulatory regions. RNP (ribonucleoprotein) immunoprecipitation revealed that the AREBP, HuR, binds to the RNase-L mRNA in intact cells, and functions to increase its mRNA half-life and expression in a manner that is dependent on the two 3'-terminal AREs. Activation of endogenous HuR in response to stress stimuli, or during myoblast differentiation, corresponded to an increase in RNase-L expression and HuR-RNase-L mRNA interaction, suggesting that HuR regulates RNase-L in physiological conditions. In addition, the HuR-dependent regulation of RNase-L expression enhanced its antiviral activity demonstrating the capacity of this regulation to impact RNase-L function. These findings provide the first description of the post-transcriptional regulation of RNase-L expression by its 3'UTR and HuR, and identify a novel mechanism by which the activity of the 2 -5A pathway is controlled.
EXPERIMENTAL PROCEDURES
Cell culture, transfection, and expression constructs.
293T, Hela, 2fTGH and C2C12 cells were grown in DMEM medium containing 10% fetal calf serum (FCS) and 1x antibiotic-antimycotic (Invitrogen, Carlsbad, CA). Cells were maintained in a humidified atmosphere of 5% CO 2 , 95% balanced air at 37 o C. To induce differentiation C2C12 myoblasts cells were grown to 80-90% confluence, then transferred to DMEM containing 2% FCS and Insulin-Transferrin-Selenium-A (ITS) (Invitrogen) for up to five days. Transfection experiments were carried out using Lipofectamine 2000 as directed by the supplier (Invitrogen). RNase-L-3'UTR expression constructs and deletion mutants used for transfection included the previously described RNase-L cDNA (25) , and are described below. The HuR expression construct was a generous gift from Myriam Gorospe (NIA). pTRE-r?β G-3'UTR construct was generated by sequential PCR amplification of the RNaseL 3'UTR with primers that added flanking BglII sites, cloning of the PCR product into the pCRblunt-Topo vector (Invitrogen), and subcloning of the BglII 3'UTR insert downstream of the rabbit β -globin gene in the pTRERβ -wt vector (26) . The pTRE-r?β G-3'UTR construct used in the experiments presented contained the poly-A signals from the RNase-L 3'UTR and the vector; however, the presence of an extra poly-A signal did not alter β globin-UTR expression or mRNA stability, as a construct that contained only the vector-derived poly-A signal gave equivalent expression (data not shown). All clones were verified by sequencing.
Cloning of the RNase-L 3'UTR and generation of 3'UTR mutants.
The human RNaseL 3'-UTR was amplified from human genomic DNA using primers that flanked the stop codon and predicted poly-adenylation site: forward: 5'GTC CCT GGC ATC GTG TAT TCC ATA3'; reverse: 5'CTC TCA CTA CAT ACT AGG CCC ACA3', and cloned in to pCR-blunt-Topo. The PCR product was subcloned into the unique SpeI site in the 3'UTR of clone ZC5 in the pcDNA3.1 vector (25) to generate the full-length RNaseL construct (ZC5+, figure 1 ). To remove the poly-A signal from the ZC5+ construct, the plasmid was amplified using forward, 5'CAC CAT GGA GAG CAG GGA TCA T3', and reverse, 5'GAG TAA GCT TCA CAA ATG GGC3', primers, and subcloned in the the pcDNA3.1 vector. To remove the poly-A signal from the pTRE-r? β G-3'UTR construct; forward primer 5'AGA TCT GGA CTG ATT TGC TGG AG3', and reverse primer, 5'AGA TCT GAG TAA GCT TCA CAA ATG GGC 3', were used and the PCR product was subcloned into the BglII sites of the parental plasmid. The cloning junctions and 3'UTR were verified by sequencing (UM,B Biopolymer Core). The primers used for PCR in figure 1B to demonstrate that the 3'UTR is contiguous with the coding region, and that the predicted poly-A site is used are listed according to the PCR products A-D shown in figure 
Analysis of RNA expression and half life by qRTPCR.
Total RNA was prepared using Trizol reagent as directed by the supplier (Invitrogen). RNA was treated with DNase1 (Promega, Madison, WI) at 37 o C for 30 minutes, followed by the addition of 1µ l of stop solution at 65 o C for 15 minutes prior to analysis by Northern blot or qPCR. For qPCR analysis, 2 µ g of DNase1 treated total RNA was used for reverse transcription to synthesize first strand cDNA using SuperScriptaseII RT (Invitrogen). Aliquots of the first strand cDNA were used in a standard PCR reaction mixture (Abgene, Epsom, Surrey, UK) or in real time PCR (qPCR) reactions using SYBR green as directed by the manufacturer (Bio-Rad, Hercules, CA ). For all primer sets, reactions were first conducted using a temperature gradient to optimize annealing conditions, and the absence of primer-dimers was confirmed by melting condition analysis. RT reactions carried out in the absence of RT served as a negative control, and to detect PCR products generated from contaminating genomic DNA. PCR reactions using plasmid templates served as positive controls To analyze the mRNA half-life of plasmid-encoded transcripts, cells were first transfected with the indicated plasmids, then, at 24 hours post transfection, the transfected cells trypsinized and seeded into individual plates for treatment with 5µ g/ml actinomycin D (Sigma, St. Louis, MO). In this manner, samples used to determine mRNA half-life were derived from a single transfection, thereby eliminating potential differences in expression associated with variable transfection efficiencies. Total RNA was harvested at the time points indicated in the figures. Specific mRNAs were quantified by qPCR. Each analysis represents at least two independent experiments, and within an experiment, all reactions were performed in triplicate, and the Ct values were converted to RNA concentration using a standard curve. mRNA values from each time point were normalized to the constitutively expressed ribosomal protein transcript, rpl13A. mRNA values were graphed on semi-log axes, and first order turnover rates were calculated by nonlinear regression of the percentage of mRNA remaining as a function of time after actinomycin-D treatment.
Western blotting
Cell lysates were prepared using RIPA buffer (Upstate Biotechnology, Charlottesville, VA). The protein concentration in the lysates was determined by the Bradford microassay (BioRad), and an equal amount of protein (30µ g/lane unless otherwise indicated in figure legends) was separated on 10% SDS-PAGE gels. Proteins were electrotransferred to Immobilon-P membrane (Millipore, Belerica, MA). The membranes were blocked in 5% nonfat milk TBST buffer (10 mM Tris pH 8.0, 150 mM NaCl, 0.1% v/v TWEEN 20) for 1 hour at room temperature, and then sequentially reacted with the primary antibody for 1 hour in blocking buffer and HRP-conjugated secondary antibody (1:10,000 dilution; Sigma). The RNase-L monoclonal antibody (provided as a generous gift from Robert Silverman, The Cleveland Clinic Foundation) was used at a 1:2000 diliution. The α -actin (Sigma-Aldrich), neomycin-resistance (Upstate Biotechnology), and HuR (SantaCruz) antibodies were used at 1:1000, 1:1000 and 1:500 dilutions respectively. The immunoreactive complex was visualized using the Pierce SuperSignal chemiluminescent substrate (Pierce Biotechnology, Rockford, IL) and exposure to X-Omat AR film (Eastman Kodak Co., NY).
RNP immunoprecipitation
RNA-protein complexes were isolated from C2C12 myoblasts at day 3.5 of differentiation by lysing cells in PBL buffer (100mM KCl, 5mM MgCl 2 , 10mM Hepes [pH 7.0], 0.5% Nonidet P-40) to preserve native RNAprotein interactions. Lysate supernatants were precleared for 1 hour at 4°C using 15 µ g of IgG (Sigma-Aldrich) and 50 µ L of protein A/GSepharose beads (Sigma-Aldrich) that had been swollen in NT2 buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM MgCl 2 , and 0.05% Nonidet P-40) supplemented with 5% bovine serum albumin. Proteins that non-specifically bound the protein-A/G-IgG complex were removed by centrifugation to generate the precleared lysate. For RNA immunoprecipitation, protein-A beads (100 µ L) were first incubated (16 h, 4°C) with 30 µ g of either IgG, goat anti-TIAR (Santa Cruz Biotechnology, Santa Cruz, CA), or anti-HuR (Upstate Biotechnology); beads were then washed 5 times in 1ml NT2 buffer before lysate was added. Precleared cell lysate (3mg) was then added to the protein-A/G-antibody complex and rotated for 2 hours at 4°C. After washing 5 times in 1ml NT2 buffer, the complexes were treated sequentially with DNAseI (5 minutes at 37 o C) then Proteinase K at (25 minutes at 55 o C). The RNA was extracted by Phenol/Chloroform and precipitated in 0.3M sodium acetate [pH 5.5]/EtOH at -20 o C for 24 hours and resuspended in dH 2 0 for analysis. The presence of specific mRNAs in the immunoprecipitated complex was determined by RTPCR using gene specific primers from the coding region of murine MyoD and RNase-L; the primers used for this analysis are: MyoD: forward 5'TAC CCA AGG TGG AGATCCTG3', reverse 5'CAT CAT GCC ATC AGAGCAGT3'; murine RNase-L: forward, 5'CAA TCG AGA AGT GGC TGTGA3', reverse, 5'ATA GGA TGC TGT GGG CAAAC3'.
Antiviral assay
Hela cells were co-transfected with RNaseL expression constructs, ZC5+ and pZeoHuR or empty vector control. At 24 hours post-transfection, cells were reseeded into 96 well plates, and treated with IFNα (PBL Biomedical Laboratories, New Brunswick, NJ) at the indicated concentrations for 16 hours, then challenged with EMCV (moi~0.1) for 10 hours. Cell viability was analyzed using the MTT assay (Promega, Madison, WI), and the percent protection was calculated using the formula: sample value -virus control (no IFN)/ cell control (no virus) -virus control (no IFN). Each value is the mean of 8 identical wells +/-standard deviation.
RESULTS

RNase-L mRNA contains a long 3'UTR with putative AREs.
The mature human RNase-L mRNA is 4.3 kB in size, with a coding region of just 2.2 kB and an extensive untranslated region (UTR) of approximately 2.1kb (25) . Primer extension analysis identified a short, ~0.37kb 5'UTR (27) indicating that the remaining 1.75kb was 3'UTR. Predicted secondary structures and poly-A stretches in the 3'UTR that resulted in RT pausing and oligo-dT binding upstream of the poly-A tail, precluded cloning of the 3'UTR by conventional RT-based approaches. However, analysis of the human genome sequence revealed a predicted poly-A site, and permitted PCR amplification of the 3'UTR from genomic DNA to generate a full length RNase-L cDNA designated ZC5+ ( figure  1A ). RTPCR using overlapping forward and reverse primer pairs beginning in the coding region and continuing through the 3'UTR to downstream of the predicted poly-A site confirmed that the 3'UTR is contiguous with the coding region, and that the predicted poly-A site is used (figure 1B; NCBI accession # 810337). Specifically, identical PCR products of the expected sizes were generated from ZC5+ and from endogenous RNase-L mRNA when primers upstream of the predicted poly-A site were used. However, PCR using a reverse primer downstream of the predicted poly-A site produced a product from the ZC5+ construct that contained this genomic sequence, but not from the untransfected sample that contained only endogenous RNase-L mRNA (lane D in figure 1B ). This finding is consistent with the use of the predicted poly-A site by endogenous RNase-L, and indicated that the ZC5+ transcript was using the vector derived poly-A signal. Sequence analysis of the 3'UTR revealed eight putative AREs with canonical AUUUA sequences that may serve as determinants of RNase-L mRNA stability. The extensive nature of the RNase-L 3'UTR, and the presence of candidate AREs suggested that it may serve an important regulatory function. Cis-acting regulatory elements are predicted to be evolutionarily conserved, therefore we compared the RNase-L 3'UTR sequence in human and mouse. The mouse RNase-L mRNA contained a 3'UTR of 1774 bases from the stop codon to the predicted polyadenylation site, which is slightly longer than the 1736 base human sequence. Clustal W alignment of the mouse and human 3'UTR revealed a modest sequence similarity across the entire 3'UTR (57% identity); however, islands of high conservation that approach the 74% identity observed in the coding region, were also detected (28) . In particular, a 3'-terminal region of 305 bases exhibited a striking 71% sequence identity between mouse and human, and contained two putative ARE elements in a uridine rich (35% U) context that characterizes functional AREs. These findings identify a conserved 3'UTR in the RNase-L mRNA that contains ARE elements and may function in the posttranscriptional regulation of RNase-L expression.
The 3'UTR is a negative regulator of RNase-L expression and mRNA stability.
The presence of a long 3'UTR is frequently indicative of post-transcriptional regulation of gene expression via modulation of mRNA stability; therefore, we investigated if the RNase-L 3'UTR modulated its expression. Transfection of 2fTGH human fibrosarcoma cells with an expression construct containing the RNase-L coding region and 200 bases of 3'UTR (designated ZC5) resulted in a robust expression of RNase-L protein ( figure 2A) ; a comparable strong expression was observed with a coding region construct, demonstrating the lack of regulatory elements in the 5'-most 200 bases of the 3'UTR (not shown). I n contrast, RNase-L expression was dramatically reduced following transfection with the full length RNase-L ZC5+ construct that contained the 3'UTR ( figure 2A ). This construct contained poly-A signals from the RNase-L sequence and from the vector; however, the presence of an extra poly-A signal did not alter RNase-L expression or mRNA stability when compared to a construct that contained only the vector-derived poly-A signal (data not shown). The transfection efficiency was determined by Western blot analysis of the vector-encoded neomycin resistance gene (neo-r); a slightly lower level of neo-r was observed in the ZC5 transfectants indicating that ZC5 was expressed to an even greater level when normalized to neo-r expression. Endogenous RNase-L was not detectable in vector transfected controls, indicating that the RNase-L expression was derived solely from the transfected constructs. The difference in ZC5 and ZC5+ protein expression corresponded to a pronounced difference in the levels of their respective mRNAs. Indeed, qPCR analysis of steady state RNase-L mRNA revealed a 3.3-fold increase in ZC5 as compared to ZC5+ transfectants (figure 2B) ; no RNase-L PCR product was detected in vector transfected cells, indicating that endogenous RNase-L mRNA did not contribute to the qPCR signal in the conditions used. Primers used for qPCR analyses included coding region and 3'UTR sequences to insure that the complete ZC5+ transcript was expressed. To determine if the 3'UTR-dependent inhibition of RNase-L expression reflected a change in RNase-L mRNA stability, 293T cells were transfected with ZC5 or ZC5+ constructs, then subcultured into multiple plates for actinomycin-D treatment and analysis of mRNA turnover by qPCR. This regimen insures equivalent transfection efficiency in all samples used to calculate mRNA half life. This analysis revealed a 3'UTR-dependent reduction in RNase-L stability from 74 minutes for ZC5, to 33.5 minutes for ZC5+ ( figure 2C ). To examine the activity of the 3'UTR independent of the RNase-L coding region, and determine if it could confer destabilizing activity to a heterologous mRNA, expression constructs encoding chimeric transcripts comprised of the stable rabbit β -globin gene fused to the RNase-L 3'UTR (β -globin-3'UTR) were generated ( figure  3A) . β -globin-3'UTR and parental β-globin plasmids were transfected into 293T cells, and mRNA was measured after actinomycin-D treatment by RTPCR ( figure 3B) . Quantitation of the mRNA by qPCR revealed a dramatic twelvefold decrease in the half life of β -globin-3'UTR as compared to the construct lacking the 3'UTR ( figure 3C) . Thus, the RNase-L 3'UTR can act in cis to potently modulate the stability of a heterologous mRNA. These findings identify a novel role for the 3'UTR in regulating RNase-L expression and mRNA stability.
Positive and negative regulatory elements in the RNase-L 3'UTR.
Eight putative ARE elements are distributed throughout the RNase-L 3'UTR, with the two 3'-most AREs (numbered 7 and 8 in figure 4A ) situated in a highly conserved, U-rich context that is characteristic of functional AREs. To determine the roles of specific AREs in RNase-L regulation, and map other cis-acting elements in the 3'UTR, deletion mutants that sequentially removed AREs were generated ( figure 4A) ; the poly-adenylation site from the vector was retained in the deletion mutants to prevent any influence of this element on RNase-L expression. Deletion constructs were transfected into 293T or HeLa cells, and RNase-L protein and mRNA were measured by Western blot and qPCR respectively (figure 4B and C). Identical patterns of 3'UTR regulation were observed in 293T and HeLa cells indicating that this regulation is not cell-type specific, and that the factors that mediate this regulation may be ubiquitously expressed. As previously demonstrated, the ZC5 construct containing the coding region and just 200 bases of 3'UTR was robustly expressed, whereas RNase-L expression from the ZC5+ construct that contains the complete 3'UTR was markedly reduced. Removal of the two 3'-most AREs (∆ 7-8) resulted in a dramatic decrease in RNase-L mRNA and protein below that observed with the complete UTR, indicating that this region functions as a positive regulator of RNase-L expression. Deletion of upstream AREs in constructs ∆ 5-8 and ∆ 4-8 increased RNase-L expression as compared to the ∆ 7-8 construct, suggesting that this region serves a negative regulatory function. ARE 1 appeared to be without effect, as its presence in a separate construct that lacked AREs 2-8 resulted in RNase-L expression similar to that observed in ZC5 or ∆ 1-8 that lack all candidate AREs (not shown).
However, restoration of AREs 2 and 3 in the ∆ 4-8 construct reduced RNase-L expression to a level comparable to that seen with the complete 3'UTR, implicating this region in negative regulation. To directly test the negative regulatory activity of AREs 2 and 3, and the positive regulatory activity of AREs 7 and 8, in the context of the full length 3'UTR, these AREs were deleted independently or in combination. Specifically, constructs in which the AUUUA motif was deleted in each single ARE mutant, and a double mutant that deleted AREs 2 and 3 as well as the 17 intervening bases, were generated. In addition, , a construct that deleted a predicted binding site for the AREBP, HuR, that lies between AREs 7 and 8, was generated ( figure  1A , and see below). Transfection of the ARE 2, 3, and double mutants into 293T cells dramatically enhanced RNase-L expression as compared to that observed with the ZC5+ construct that contains both AREs 2 and 3 ( figure 4D ). Thus, deletion of either ARE independently, or in combination, had a similar effect on RNase-L expression. In contrast, deletion of AREs 7, 8, or the predicted HuR binding site did not alter RNase-L expression compared to that observed with the ZC5+ construct (figure 4E), suggesting that these AREs constitute interdependent elements, all of which are required for regulatory activity. These findings implicate AREs 2 and 3 in maintaining the low levels of basal RNase-L expression that are observed in most cell types, whereas AREs 7 and 8 appeared to mediate a positive regulatory function. In light of the high sequence conservation and U-rich context of the region comprising AREs 7-8, and the paucity of information on the mechanisms by which RNase-L expression is upregulated, we focused our studies on determining the mechanism by which this cis element regulates RNase-L expression.
HuR regulates RNase-L expression in a 3'UTRdependent manner.
The impact of AREs on mRNA stability occurs through their interaction with RNABPs and associated proteins. HuR is an RNA binding protein that stabilizes ARE-containing mRNAs, and deletion analysis of the RNase-L 3'UTR identified a strong positive regulatory element in the region containing the two 3'-most AREs ( figure 4) ; therefore, we hypothesized that HuR may mediate the increase in RNase-L expression that is associated with this region of the 3'UTR. A global screen for HuR target mRNAs by RNP immunoprecipitation recently identified a consensus sequence for HuR interaction (29) , and analysis of the RNase-L 3'UTR revealed the presence of a predicted HuR binding site located between AREs 7 and 8 ( figure 1A ). To determine the potential role of HuR in the 3'UTR-dependent regulation of RNase-L, HeLa cells were cotransfected with ZC5, ZC5+ or ∆ 7-8 constructs, and a HuR expression construct or control vector. Analysis of RNase-L protein revealed a dramatic, 3.6-fold, HuR-dependent increase in expression in ZC5+ transfected cells, whereas HuR had no effect on RNase-L expression from the ZC5 construct lacking the 3'UTR ( figure 5A ). An identical pattern of HuR-dependent regulation was observed when 293T cells were used for transfection (not shown). Thus, HuR mediates a 3'UTR-dependent increase in RNase-L expression. To determine if HuR enhanced RNase-L expression through its predicted binding site in the 3' terminal region of the RNase-L 3'UTR, HeLa cells were transfected with the ∆ 7-8 construct and HuR or vector control. HuR-dependent regulation of RNase-L expression was markedly reduced in cells transfected with construct ∆ 7-8 that lacked the predicted HuR binding site (figure 5A), indicating that the region deleted in construct ∆ 7-8 is essential for HuRmediated regulation of RNase-L. However, normalization of the RNase-L signal to neo-r to account for differences in transfection efficiency revealed a 1.3 fold HuR mediated increase in expression from the ∆ 7-8 construct suggesting that HuR may exert minor effects on RNase-L expression independent of the RNase-L 3'UTR ARE 7-8 domain. A primary mechanism by which HuR regulates expression of its target mRNAs is through modulation of mRNA stability; therefore, we examined if the HuR-dependent increase in RNase-L protein expression reflected a change in its mRNA half-life. Co-transfection of HuR with ZC5+ resulted in a dramatic stabilization of RNase-L mRNA as compared to cells transfected with ZC5+ and control vector (figure 5B). In contrast, HuR had a reduced impact on the halflife of the ∆ 7-8 mRNA that lacked the predicted HuR binding site ( figure 5C ). Taken together, these findings identify a novel role for HuR in the 3'UTR-dependent regulation of RNase-L mRNA stability and expression.
Enhanced expression, and physical association of RNase-L mRNA with HuR in conditions of endogenous HuR activation.
HuR is an established RNA binding protein that increased the mRNA stability and protein level of ectopically expressed RNase-L in a manner that is dependent on its 3'UTR (figure 5). To determine if the endogenous RNase-L transcript is a target of HuR interaction, RNPimmunoprecipitation (RNPIP) was used to isolate mRNAs that interact with HuR in native conditions that preserve intracellular RNA-protein interactions (30) . RTPCR of RNA isolated from the immunoprecipitates was then used to detect the presence of RNase-L mRNA in the HuR IP complex. For this analysis, we used the C2C12 murine myoblast system in which cytoplasmic HuR protein and endogenous RNase-L mRNA are coordinately increased during differentiation (31, 32) . In addition, differentiating myoblasts are one of the few cell types in which endogenous RNase-L mRNA is increased above very low basal levels (33) . We first used RTPCR analysis to confirm the induction of RNase-L mRNA during the differentiation of murine C2C12 myoblasts; the endogenous RNase-L transcript was undetectable in resting myoblasts and increased to a maximal level at day 3.5 of differentiation before returning to basal levels in fully differentiated myotubes (figure 6A). A concomitant increase in cytoplasmic HuR protein was observed in these samples (figure 6B). Accordingly, HuR was immunoprecipitated from C2C12 myoblasts at day 3.5 of differentiation, and the presence of HuRbound RNase-L mRNA was analyzed by RTPCR. HuR-bound RNase-L mRNA was readily detected in the IP from differentiating, day 3.5, myoblasts, and corresponded to the increase in RNase-L mRNA observed at that time point (figure 6C). RTPCR following immunoprecipitation with the control IgG did not result in any RNase-L-specific PCR product. To determine if the interaction of RNase-L mRNA was specific for HuR, or if it reflected a more general interaction with AREBPs, RNPIP was performed with antibody to a distinct AREBP, TIAR (TIA-1-Related). RNase-L mRNA was not detected following immunoprecipitation with the TIAR antibody indicating that the RNase-L mRNA interacts specifically with HuR ( figure  6C) ; however, we cannot rule out interactions with other AREBPs not tested in this study. The Myo-D mRNA is known to interact with HuR and TIAR (29, 31) , and was immunoprecipitated with both HuR and TIAR antibodies providing a positive control for the RNPIP analysis. These findings provide the first evidence of an interaction between endogenous RNase-L mRNA and the HuR IP complex in a physiological setting.
It is well established that cell stress stimuli, including heat shock and UVC irradiation, result in an increase in cytoplasmic HuR, and HuRdependent modulation of target gene expression (34, 35) . To extend the analysis of RNase-L regulation to conditions of endogenous HuR activation, we examined the role of the 3'UTR in RNase-L expression following heat shock or UVC-induced cell stress. 293T cells were transfected with ZC5 or ZC5+ for 24 hours prior to treatment with heat shock or UVC radiation. Both stress stimuli induced RNase-L expression in ZC5+ transfected cells, whereas no change in expression was observed in cells transfected with the ZC5 construct that lacks the 3'UTR (figure 7). These observations suggest a role for the RNase-L 3'UTR in its stress-induced expression.
HuR-mediated regulation of RNase-L modulates its antiviral activity.
RNase-L is a well established mediator of cellular antiviral activity; therefore, we sought to determine if the HuR-mediated regulation of RNase-L expression resulted in a functional impact on this biological function. HeLa cells were co-transfected with ZC5+, 
DISCUSSION
Genes that mediate critical cellular functions in host defense, tumor suppression, and stress response, such as RNase-L, must be tightly regulated. Aberrant overexpression or activation of such genes can result in dysregulated cell death and inflammatory syndromes, whereas a deficiency in expression can result in enhanced susceptibility to microbial infections and cancer. RNase-L activity is regulated at many levels, from the expression and activation of OAS family members to the degradation of 2-5A by cellular enzymes. A protein inhibitor of RNase-L, RLI, has also been described (13) . In contrast, there is little information on the regulation of RNase-L gene expression per se, and few examples of significant variations in RNase-L mRNA or protein from the low basal levels that are found in most cell types have been reported (24) . Analysis of the RNase-L promoter failed to identify strong regulatory elements (27), suggesting that post-transcriptional mechanisms may be important in regulating RNase-L expression. In fact, ectopic expression of RNase-L results in apoptosis or senescence depending on the cell type (16) , demonstrating that changes in the level of cellular RNase-L can mediate biological activities in the absence of specific inducers of its activator, 2-5A (e.g. IFN, virus infection). Accordingly, regulated, transient changes in RNase-L mRNA or protein may result in potent biological effects. Consistent with this prediction, we have characterized the extensive 3'UTR found in RNase-L mRNA, and have determined that it functions as a positive and negative regulator of RNase-L expression and activity.
The RNase-L 3'UTR functions in cis to regulate its expression.
Regulatory elements in the untranslated regions of mRNAs are frequently well conserved; therefore, we compared the mouse RNase-L 3'UTR, with the human sequence to identify conserved regions that may serve a regulatory function. Islands of high sequence identity between the mouse and human orthologues were detected around several candidate AREs, consistent with the established function of these elements in post-transcriptional gene regulation. The full length 3'UTR exerted a potent inhibitory effect on RNase-L or β -globin expression and mRNA stability (figure 2), suggesting that 3'UTRdependent regulation is an important mechanism by which RNase-L mRNA is maintained at low levels in the absence of cell stress. The ZC5+ construct was consistently expressed at a reduced level as compared to that of ZC5. However, differences in the exact ZC5+/ZC5 expression ratio were observed that may reflect variations in the endogenous factors that mediate this regulation. Indeed, AREBP expression and activity may be modulated by variations in cell density and proliferative status that, in turn could impact 3'UTR mediated RNase-L expression (1). Deletion analysis revealed that the presence of AREs 2 and 3, but not 1, resulted in expression that was comparable to that of the full 3'UTR (figure 4), implicating these AREs in this negative regulatory activity. Interestingly, deletion of AREs 2 and 3 independently, or in combination, resulted in a similar increase in RNase-L expression, suggesting that these AREs comprise a single regulatory element that can be functionally disrupted by the loss of either ARE ( figure 4D) . Indeed, computer modeling suggests that the ARE 2-3 region exhibits a potential secondary structure that may reflect this composite element (36) .
The most highly conserved region comprised 305 bases in the 3' end of the 3'UTR; deletion of this region reduced RNase-L expression below that observed with the full 3'UTR, indicating that it served a positive regulatory function (figure 4). Independent deletion of AREs 7 and 8 that fall within this region did not mimic the reduction in RNase-L expression observed in the ∆ 7-8 mutant that lacked this entire region ( figure 4E) . Furthermore, deletion of the predicted HuR binding site that lies between AREs 7 and 8 also failed to replicate the activity of the ∆7-8 mutant ( figure 4E) . Thus unlike the closely spaced AREs 2 and 3, AREs 7 and 8, which are separated by 295 bases, may form interdependent structures or binding sites both of which are required for regulatory activity. Consistent with this prediction, computer modeling of the highly conserved regions around these elements, and the predicted HuR binding site, identified potential secondary structures (not shown; (36) . Indeed, 3'UTR secondary structure is an important determinant of protein interaction and corresponding regulation (1, 5) . Further studies are required to analyze the formation of secondary structures in the RNase-L 3'UTR.
Taken together, our results indicate that distinct elements in the RNase-L 3'UTR mediate positive and negative regulatory activities. A similar bifunctional role for the 3'UTR has been described for other labile mRNAs including p21 and cyclin D1 (37) . In that study, HuR and AUF1 were both associated with p21 and cyclin D1 mRNAs in the nucleus, but independently bound these transcripts in the cytoplasm to promote stabilization or degradation depending on the physiological context. The combined impact of the multiple elements in the RNase-L 3'UTR in distinct biological settings remains to be determined.
HuR mediates a 3'UTR-dependent increase in RNase-L expression.
In light of the established role of HuR in stabilizing target mRNAs, and the paucity of information on mechanisms that enhance RNase-L expression, we focused our studies on the potential role of this positive regulatory region in RNase-L expression. HuR is a constitutively expressed AREBP that is translocated from the nucleus in resting cells to the cytoplasm in response to diverse stress stimuli (6, 38, 39) . Cytoplasmic HuR is associated with an increase in stability or translation of its target mRNAs (38) .
Cotransfection of HuR and RNase-L 3'UTR deletion mutants demonstrated that HuR enhanced RNase-L expression and mRNA stability in a manner dependent on the predicted HuR binding site between AREs 7 and 8 ( figure 5) . Moreover, RNase-L mRNA was identified in a HuR RNPIP complex indicating that it interacted with HuR or associated proteins (figures 5 and 6). As a target of HuR regulation, RNase-L may represent an important effector of biological activities associated with HuR action. Consistent with a role for RNase-L as a physiologic HuR target, activation of HuR by cell stress or myogenic differentiation correlated with an increase in endogenous RNase-L expression, (figure 7). In addition, both HuR and RNase-L function in replicative senescence (40) , cellular proliferative control (14, 41) , and the innate immune response (7, 15) , suggesting that HuR may regulate RNase-L in a broad spectrum of conditions. However, genetic ablation of HuR and RNase-L in specific physiological contexts is required to definitively evaluate the role of RNase-L mRNA as a HuR target. ARE-dependent gene regulation is the target of several signaling pathways, and the stabilization of ARE-containing mRNAs by HuR is frequently linked to p38 mitogen-activated protein (MAP) kinase activation (42) . Interestingly, pharmacologic inhibition of p38 did not alter the expression of ZC5 or ZC5+ (not shown), suggesting that the RNase-L AREs function independent of p38 signaling, or that a second stimulus, such as cytokine or microbial stimulation, is required. Finally, a novel mechanism in which HuR binding modulates the access of miRNAs to their target mRNAs was recently described (43) . The RNase-L 3'UTR is a predicted target for several miRNAs, and ongoing studies are testing their roles in conjunction with HuR, in the post-transcriptional regulation of RNase-L expression.
Taken together, our findings support a model in which the RNase-L 3'UTR functions to maintain its mRNA at low basal levels in resting cells, but acts to increase RNase-L expression in conditions of cell stress. It is likely that the changes in RNase-L mRNA resulting from alterations in its mRNA stability have not been previously detected due to their transient nature. Indeed, RNase-L upregulation and activation provides a mechanism to rapidly change the cellular gene expression profile in response to stress stimuli; however, its expression must then be efficiently attenuated to prevent the potential deleterious effects of its widespread activity.
Concurrent transcriptional changes in the expression of genes encoding RNase-L targets may function to maintain the new, stress-induced, gene expression setpoint.
3'UTR-mediated regulation in the biological activities of RNase-L.
Our finding of a novel level of posttranscriptional regulation for RNase-L that was mediated by cis elements in its 3'UTR, and by the AREBP, HuR, suggested that this regulation may function in the established biological activities of RNase-L. In fact, ectopic HuR expression increased the antiviral activity of RNase-L ( figure  8 ). In contrast, transfection of HuR alone had little impact on antiviral activity, suggesting that endogenous levels of HuR are sufficient to regulate endogenous RNase-L. Surprisingly, a HuR-dependent increase in antiviral activity was also observed in cells transfected with the ∆ 7-8 construct that lacks the predicted HuR binding site. This finding suggested that HuR may regulate RNase-L by binding to sites other that that in the ARE 7-8 region. A role for the post-transcriptional regulation of RNase-L in its antiviral and tumor suppressive functions predicts that the effectors of this regulation may be inactivated in virus-infected cells and in tumors that have escaped the constraints of RNase-L action. Consistent with this idea, HuR expression was altered in CMVinfected cells resulting in a compromised antiviral activity (44) , and aberrant regulation of HuR was detected in HPV18-associated cervical neoplasia (45) . Altered expression of HuR and HuR target mRNAs has also been reported in cancers of the breast (46), gut (47) , ovary (48) , and colon (49) . These studies suggest a role for dysregulated HuR expression in the etiologies of human viral infections and malignancies; however, the importance of RNase-L, as compared to other HuR targets, in these pathologies remains to be determined. The identification of gene products that mediate the post-transcriptional regulation of RNase-L expression, such as HuR, may reveal novel strategies targets to enhance RNase-L expression and activity for therapeutic applications. Interestingly, analysis of SNP databases revealed a clustering of SNPs in the RNase-L 3'UTR suggesting that it may be a region of genetic sequence diversity; the functional significance of these variants with respect to RNase-L expression, and the occurrence of 3'UTR SNPs in human diseases are subjects of current investigation.
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*Acknowledgements: We thank Myriam Gorospe, NIA, Ron Gartenhaus, and Janette Harro, University of Maryland Greenebaum Cancer Center, for critical discussion of the manuscript. Figure 1 . Cloning and annotation of the human RNase-L 3'UTR. A. Sequence: the coding region, and the genomic sequence that is 3'of the pA addition site are shaded; the 'A' of UGA stop codon is base 2393 of NCBI accession# NM_021133; the stop codon and polyA signal are boxed; AUUUA motifs are in bold and boxed; the predicted HuR binding site is in bold italics; reverse primers used to generate the deletion constructs are underlined in bold. B. RTPCR analysis of the RNase-L 3'UTR. Primer locations, PCR strategy, and predicted PCR products are shown in the diagram; the solid rectangle represents the coding region, and the thin line designates the 3'UTR. RNA samples from untransfected, ZC5+ transfected 293T cells were used for RTPCR analysis as depicted in the diagram, and a photograph of the ethidium bromide stained gel is shown. Product D was generated from the ZC5+ plasmid to confirm the presence of the genomic sequence downstream from the poly-A site in that construct. Lanes are labeled corresponding to the diagram and indicate the specific PCR product generated; X, unused lane; RT-, negative control performed in the absence of RT; M, molecular mass markers are 4.0, 3.0, 2.0, 1.5, 1.0, and 05.kb. Figure 8 . HuR impacts the antiviral activity of RNase-L. HeLa cells were transfected with ZC5+ or ∆ 7-8, and HuR or control vector, then pretreated with the indicated amounts of IFNα prior to infection with EMCV. Murine IFNα was prepared by serial 1:3 dilutions from a 1000U/ml stock. Viable cells were measured by MTT at 10 hours post-infection. The percent protection was calculated as described in Materials and Methods. Note that the standard deviation for this experiment was <0.5% of the value for each condition, therefore error bars cannot be visualized on the scale of the graph.
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